Practice Management News

The FDA tentatively approved certain Brixadi injections for treatment of moderate to severe opioid use disorder, according to a press release from Braeburn, the drug manufacturer.

HHS issued new guidance today that recommends prescribing or co-prescribing naloxone and providing education about this treatment in patients at high risk for opioid overdose, according to a press release.

The U.S. Preventive Services Task Force recently announced it will, for the first time, review the evidence on preventing prescription and illicit opioid use disorder, according to a press release.

Leaders from several states vowed appeals to stave off the consequences to health care after a district judge from Texas ruled that when Congress eliminated the penalty for not buying health insurance, the individual mandate was no longer constitutional under Congress' taxation powers, The Los Angeles Times reported.

The United States-Mexico-Canada Agreement keeps drug prices high but could potentially spur new research opportunities, a pharmaceutical expert told Healio Family Medicine.

The FDA has approved a mobile medical app that could increase the time a patient participates in an outpatient treatment program for opioid use disorder, according to a FDA press release.

Only 15.4% of physicians worked in practices that utilized telemedicine for patient interactions, such as diagnosing or treating patients, managing patients with chronic conditions or following up with patients, according to an AMA press release.

The 10 leading causes of death in the United States in 2017 were the same as 2016, with heart disease and cancer topping the list, according to a National Center for Health Statistics Data Brief published by the CDC.

Cultivating effective discussions that were focused on the patient were likely to improve opioid tapering outcomes, according to research recently published in the Journal of Pain.

FDA Commissioner Scott Gottlieb, MD, has issued a new warning about kratom, stating that the agency found “disturbingly high levels of heavy metals” in 26 kratom products.